Ibnsina to distribute Novartis’ Alcon products in Egypt: Ibnsina Pharma will distribute global eye care product manufacturer Novartis’ Alcon’s products in Egypt, according to a company statement (pdf). The newly inked agreement lends further credence to the argument “that exclusivity is dying in the pharma market,” Ibnsina Co-CEO Omar Abdel Gawad says. As the fastest growing distributor in Egypt, suppliers who want to grow at or above the market growth rate, have to contract with Ibnsina Pharma to achieve their targets.”
More from Enterprise
Egypt continues to issue LCs as usual
LCs continue to be processed — albeit after closer inspection…
EGX kicks off first day of futures trading on the EGX
The rollout includes 3- and 6-month future contracts tracking the…
Beltone to launch Fadda, Egypt’s first-ever silver investment fund
Good afternoon, friends, and (almost) Eid Mubarak. With Ramadan on…
How Egypt’s fintech players can own the digital Eidiya evolution
💸 Eid traditions in Egypt (and the region) have held…